The 2 Biggest Casualties From the Celgene-Bristol-Myers Merger (So Far)

The 2 Biggest Casualties From the Celgene-Bristol-Myers Merger (So Far)

Submitted by admin on June 28, 2019 - 10:14am
Source: 
Yahoo/Motley Fool
News Tags: 
Bristol-Myers Squibb
Celgene
M&A
BeiGene
tislelizumab
Otezla
Headline: 
The 2 Biggest Casualties From the Celgene-Bristol-Myers Merger (So Far)
snippet: 

Celgene (NASDAQ: CELG) and Bristol-Myers Squibb (NYSE: BMY) were scheduled to say their official "I dos" in the coming months, but this blended family isn't starting off in Brady Bunch fashion.

Do Not Allow Advertisers to Use My Personal information